The coming year is full of uncertainty for pharmaceutical manufacturers and one critical proposed change may have been overlooked. While the fate of the Affordable Care Act, and the implications of any repeal or modification have dominated most discussions, relatively little focus has been placed on the potential impact of House Speaker Paul Ryan’s intentions […]Read Full Article
Welcome to the Blue Fin Group Information Library. Our consultants regularly publish white papers, case studies and articles, lead workshops, deliver speaking engagements, and share opinions on topics of interest to decision makers in the healthcare industry.
You don’t become an industry leader without having alot to say—click on the video vignettes below to hear our expert’s perspectives on a range of topics.
Blue Fin Group is often sought out as an expert commentator by industry publications — featuring our latest thinking and timely insights on the issues that matter most to the healthcare industry.
Blue Fin Group keeps a lens trained on many facets of the healthcare industry, and our white papers focus on singular topics that are relevant and timely. Known for our out-of-the-box thinking, these insights provide a deeper dive or different viewpoint from what others in the industry provide.
Case studies that show the transformation from challenge to solution. Each one details the existing situation, Blue Fin Group’s unique approach, the solution deployed, and the results achieved on behalf of the client. At Blue Fin Group, we deliver Deep Knowledge. Powerful Results.
Deep knowledge, unique insights and powerful perspectives focused on the healthcare industry, provided by Blue Fin Group associates.
Every year new, complex therapies are introduced to address diseases typically treated by physician specialties that may not be accustomed to in-office procedures, or to patients that have already been receiving more-traditional therapies to treat their disease. Naturally, manufacturers of these new therapies will likely need to provide an additional level of support for physicians […]Read Full Article
Most manufacturers have an array of data assets at their disposal for deeper analysis of many of the issues facing their business. However, these assets often remain sequestered within the purview of the various groups that use them for their specific business processes. Few organizations are aware of the potential that could be unleashed if […]Read Full Article